Oral Oncology
Volume 45, Issue 1 , Pages 52-58 , January 2009

Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: The role of standardized uptake value

  • Sheng-Chieh Chan

      Affiliations

    • Molecular Imaging Center and Department of Nuclear Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 333 Taoyuan, Taiwan
    • Department of Head and Neck Oncology Group, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan
    • ,
  • Joseph Tung-Chieh Chang

      Affiliations

    • Department of Radiation Oncology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan
    • Department of Head and Neck Oncology Group, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan
    • ,
  • Hung-Ming Wang

      Affiliations

    • Division of Haematology/Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan
    • Department of Head and Neck Oncology Group, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan
    • ,
  • Chien-Yu Lin

      Affiliations

    • Department of Radiation Oncology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan
    • Department of Head and Neck Oncology Group, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan
    • ,
  • Shu-Hang. Ng

      Affiliations

    • Department of Diagnostic Radiology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan
    • Department of Head and Neck Oncology Group, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan
    • ,
  • Kang-Hsing Fan

      Affiliations

    • Department of Radiation Oncology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan
    • Department of Head and Neck Oncology Group, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan
    • ,
  • Shy-Chyi Chin

      Affiliations

    • Department of Diagnostic Radiology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan
    • Department of Head and Neck Oncology Group, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan
    • ,
  • Chua-Ta Liao

      Affiliations

    • Division of Head and Neck Surgery, Department of Otorhinolaryngology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan
    • Department of Head and Neck Oncology Group, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan
    • ,
  • Tzu-Chen Yen

      Affiliations

    • Molecular Imaging Center and Department of Nuclear Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 333 Taoyuan, Taiwan
    • Department of Head and Neck Oncology Group, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan
    • Corresponding Author InformationCorresponding author. Address: Department of Nuclear Medicine, Chang Gung Memorial Hospital, Linkou Medical Center, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan. Tel.: +886 3 3281 200x2673.

Received 15 February 2008 ,Revised 18 March 2008 ,Accepted 19 March 2008.

References 

  1. Marks JE, Phillips JL, Menck HR. The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer. 1998;83(3):582–588
  2. Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet. 2005;365(9476):2041–2054
  3. Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60(5):1440–1450
  4. Ma BB, Chan AT. Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma. Cancer. 2005;103(1):22–31
  5. O’Sullivan B. Nasopharynx cancer: therapeutic value of chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S118–S121
  6. Liu FY, Chang JT, Wang HM, Liao CT, Kang CJ, Ng SH, et al. [18F]fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging. J Clin Oncol. 2006;24(4):599–604
  7. Liu FY, Lin CY, Chang JT, Ng SH, Chin SC, Wang HM, et al. 18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma. J Nucl Med. 2007;48(10):1614–1619
  8. Yen TC, Chang JT, Ng SH, Chang YC, Chan SC, Lin KJ, et al. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. J Nucl Med. 2005;46(3):405–410
  9. Allal AS, Dulguerov P, Allaoua M, Haenggeli CA, El-Ghazi el A, Lehmann W, et al. Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol. 2002;20(5):1398–1404
  10. Allal AS, Slosman DO, Kebdani T, Allaoua M, Lehmann W, Dulguerov P. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-d-glucose. Int J Radiat Oncol Biol Phys. 2004;59(5):1295–1300
  11. Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol. 2004;22(16):3255–3260
  12. Kidd EA, Siegel BA, Dehdashti F, Grigsby PW. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer. 2007;110(8):1738–1744
  13. Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, et al. [18F] fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol. 2005;23(6):1136–1143
  14. Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, Verbeken EK, Deneffe GJ, et al. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol. 1999;17(10):3201–3206
  15. Chan SC, Yen TC, Ng SH, Lin CY, Wang HM, Liao CT, et al. Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management. J Nucl Med. 2006;47(9):1447–1454
  16. Metz CE. ROC methodology in radiologic imaging. Invest Radiol. 1986;21(9):720–733
  17. Greene FL PI, Fritz AG, Balch CM, Haller DG, Monica M. AJCC cancer staging maunal. 9th ed.. New York: Springer; 2002;
  18. Lee AW, Poon YF, Foo W, Law SC, Cheung FK, Chan DK, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992;23(2):261–270
  19. Chua DT, Sham JS, Wei WI, Ho WK, Au GK. The predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma. Cancer. 2001;92(11):2845–2855

PII: S1368-8375(08)00097-3

doi: 10.1016/j.oraloncology.2008.03.010

Oral Oncology
Volume 45, Issue 1 , Pages 52-58 , January 2009

Article Tools

* Image Usage & Resolution